146 related articles for article (PubMed ID: 2783373)
21. Effectiveness of pentostatin (2'-deoxycoformycin) in refractory lymphoid neoplasms.
Spiers AS; Ruckdeschel JC; Horton J
Scand J Haematol; 1984 Feb; 32(2):130-4. PubMed ID: 6608139
[TBL] [Abstract][Full Text] [Related]
22. Hairy-cell leukemia: induction of complete remission with pentostatin (2'-deoxycoformycin).
Spiers AS; Parekh SJ; Bishop MB
J Clin Oncol; 1984 Dec; 2(12):1336-42. PubMed ID: 6334721
[TBL] [Abstract][Full Text] [Related]
23. Sequential administration of recombinant interferon alpha and deoxycoformycin in the treatment of hairy cell leukaemia.
Habermann TM; Andersen JW; Cassileth PA; Bennett JM; Oken MM
Br J Haematol; 1992 Apr; 80(4):466-71. PubMed ID: 1581231
[TBL] [Abstract][Full Text] [Related]
24. Pentostatin in the treatment of advanced hairy cell leukemia.
Kraut EH; Bouroncle BA; Grever MR
J Clin Oncol; 1989 Feb; 7(2):168-72. PubMed ID: 2783731
[TBL] [Abstract][Full Text] [Related]
25. Treatment of hairy cell leukemia with alternating cycles of pentostatin and recombinant leukocyte A interferon: results of a phase II study.
Martin A; Nerenstone S; Urba WJ; Longo DL; Lawrence JB; Clark JW; Hawkins MJ; Creekmore SP; Smith JW; Steis RG
J Clin Oncol; 1990 Apr; 8(4):721-30. PubMed ID: 2313337
[TBL] [Abstract][Full Text] [Related]
26. What is the choice of treatment for hairy cell leukemia?
Golomb HM; Ratain MJ; Moormeier J
J Clin Oncol; 1989 Feb; 7(2):156-8. PubMed ID: 2783730
[No Abstract] [Full Text] [Related]
27. The role of pentostatin (2'-deoxycoformycin, dCF) in the management of lymphoproliferative malignancies.
Spiers AS
Blood Rev; 1987 Jun; 1(2):106-10. PubMed ID: 3332090
[TBL] [Abstract][Full Text] [Related]
28. 2'-Deoxycoformycin after failure of alpha-interferon in hairy cell leukemia.
Durrleman S; Grem JL; Cheson BD
Eur J Haematol; 1989 Oct; 43(4):297-302. PubMed ID: 2583256
[TBL] [Abstract][Full Text] [Related]
29. Long-term follow-up of patients with hairy cell leukaemia treated with pentostatin: lymphocyte subpopulations and residual bone marrow infiltration.
Thaler J; Grünewald K; Gattringer C; Ho AD; Weyrer K; Dietze O; Stauder R; Fluckinger T; Lang A; Huber H
Br J Haematol; 1993 May; 84(1):75-82. PubMed ID: 8338781
[TBL] [Abstract][Full Text] [Related]
30. Biochemical changes induced in hairy-cell leukemia following treatment with the adenosine deaminase inhibitor 2'-deoxycoformycin.
Johnston JB; Begleiter A; Pugh L; Leith MK; Wilkins JA; Cavers DJ; Israels LG
Cancer Res; 1986 Apr; 46(4 Pt 2):2179-84. PubMed ID: 2418965
[TBL] [Abstract][Full Text] [Related]
31. Clinical consequences of 2'-deoxycoformycin treatment in patients with refractory adult T-cell leukaemia.
Yamaguchi K; Yul LS; Oda T; Maeda Y; Ishii M; Fujita K; Kagiyama S; Nagai K; Suzuki H; Takatsuki K
Leuk Res; 1986; 10(8):989-93. PubMed ID: 3489140
[TBL] [Abstract][Full Text] [Related]
32. Clinical response to deoxycoformycin in chronic lymphoid neoplasms and biochemical changes in circulating malignant cells in vivo.
Ho AD; Ganeshaguru K; Knauf WU; Dietz G; Trede I; Hunstein W; Hoffbrand AV
Blood; 1988 Dec; 72(6):1884-90. PubMed ID: 3264192
[TBL] [Abstract][Full Text] [Related]
33. [Therapeutic aspects of hairy cell leukemia].
Rosa F; Casciaro S; Gatti AM; Boccaccio P; Ghio R
Recenti Prog Med; 1989 Jan; 80(1):37-44. PubMed ID: 2469113
[TBL] [Abstract][Full Text] [Related]
34. Pentostatin (2'deoxycoformycin) for the treatment of lymphoid neoplasms.
Ho AD; Thaler J; Willemze R; Lauria F; Derossi G; Kuse R; Stryckmans P; Blanc CM; Cataldo F; McVie G
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():60-2. PubMed ID: 2653520
[TBL] [Abstract][Full Text] [Related]
35. Biochemical consequences of 2'-deoxycoformycin treatment in a patient with T-cell lymphoma. Some unusual findings.
de Korte D; Haverkort WA; van Leeuwen EF; Roos D; van Gennip AH
Cancer; 1987 Aug; 60(4):750-5. PubMed ID: 3496148
[TBL] [Abstract][Full Text] [Related]
36. Successful chemotherapy with deoxycoformycin in adult T-cell lymphoma-leukaemia.
Daenen S; Rojer RA; Smit JW; Halie MR; Nieweg HO
Br J Haematol; 1984 Dec; 58(4):723-7. PubMed ID: 6097297
[TBL] [Abstract][Full Text] [Related]
37. Specific immunosuppressive effects of constant infusion of 2'-deoxycoformycin.
Trotta PP; Tedde A; Ikehara S; Pahwa R; Good RA; Balis ME
Cancer Res; 1981 Jun; 41(6):2189-96. PubMed ID: 6972248
[TBL] [Abstract][Full Text] [Related]
38. The clinical pharmacology of the adenosine deaminase inhibitor 2'-deoxycoformycin.
Smyth JF; Paine RM; Jackman AL; Harrap KR; Chassin MM; Adamson RH; Johns DG
Cancer Chemother Pharmacol; 1980; 5(2):93-101. PubMed ID: 6970630
[TBL] [Abstract][Full Text] [Related]
39. Successful treatment of hair cell leukemia with 2'-deoxycoformycin after failure of interferons alpha or beta.
Dutcher JP; Salva KM; Wiernik PH
Am J Clin Oncol; 1990 Aug; 13(4):290-3. PubMed ID: 2198792
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic selectivity of and predication of response to 2'-deoxycoformycin in acute leukaemia.
Prentice HG; Russell NH; Lee N; Ganeshaguru K; Blacklock H; Piga A; Smyth JF; Hoffbrand AV
Lancet; 1981 Dec; 2(8258):1250-4. PubMed ID: 6118669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
